Loading in 2 Seconds...
Loading in 2 Seconds...
Increasing prevalence cancer, auto-immune disease or other life threatening disease and use of specifically targeting biopharmaceutical products is driving the growth of this market.\n
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
During 2017 -2025
Therapeutic monoclonal antibodies (mAbs) are glycoproteins produced by living cell systems
and the process is known as protein glycosylation. The glycan moieties attached to the proteins
directly affects in-vivo bioactivity, stability, solubility and metabolic activity of bio therapeutics
or biopharmaceutical products. Glycosylation is a post-translational modification and, is a non-
template driven enzymatic modification process. Its structure largely depends up on production
methods and conditions. Due to this reason the product can change when it is being prepared.
Biopharmaceutical products including monoclonal antibodies and other recombinant products
such as, growth factors, hormones, cytokines and therapeutic enzymes which are approved or
under development for the treatment of life threatening condition. Bioavailability and stability of
these biopharmaceutical products depend on glycan moieties attached to them. Therefore glycan
moiety of protein product must be analysed and controlled properly to ensure quality of product.
Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/15712
Increasing use of biopharmaceutical products is major factor driving the growth of glycan
analysis market. Increasing prevalence cancer, auto-immune disease or other life threatening
disease and use of specifically targeting biopharmaceutical products is driving the growth of this
market. Increasing focus of pharmaceutical companies and research institutes is also driving
growth in this market. Complexity of protein glycosylation pauses a challenge in the for the
Over the past few years use of biopharmaceutical products in increasing due to the targeted
action. These biopharmaceutical products are being approved by regulatory agencies as these are
more effective in treating life threatening and genetic disease. Due to these factors glycan
analysis market is expected to show significant growth over the forecast period. Other factors
which are expected to contribute in the growth of glycan analysis market is increasing production
of biosimilars. As glycan analysis is essential method for analysing and controlling quality
glycoproteins which are used in manufacturing and development of biosimilars. Mass
spectroscopy segment is expected to be fastest and highest revenue generating analysis segment
of glycan analysis market due to high accuracy of mass spectroscopy in defining structure of
glycan. Among the end user segment biopharmaceutical companies is expected to be most
attractive and highest revenue generating segment of glycan analysis market over the forecast
period attributing to the focus of these companies on development of biosimilars products.
Research institutes segment is also expected to show significant growth as major focus of this
segment is on development of biopharmaceutical products for treatment of life threatening
Geographically, the global glycan analysis market can be segmented into North America, Latin
America, Europe, Asia Pacific and Middle East & Africa. North America market is expected to
be most attractive and highest revenue generating glycan analysis market owning to the factor
that North America is biggest biopharmaceutical market and major players are present in this
region. Fast approval of biopharmaceutical products by regulatory agency is also driving the
growth of glycan analysis market in this region. Followed by which is Europe. Asia-Pacific is
expected to be fastest growing market due to the presence of strong generic manufacturers and
focus of key players on this region.
Request to View Sample of Research Report
Some of the key players in global glycan analysis market are Sartorius Stedim BioOutsource
Limited, S-Bio Vaupell Holdings, Inc., ProZyme, Thermo Fisher Scientific,Waters Corp.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses
achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-
disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources.
By deploying real-time data collection, big data, and customer experience analytics, we deliver
business intelligence for organizations of all sizes.
Persistence Market Research
NY 10007, United States,
Telephone – +1-646-568-7751
USA – Canada Toll Free: 800-961-0353